Laila Hassanian Emara (Laila H Emara)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Room Temperature

Loop Mediated Isothermal Amplification

Molecularly Imprinted

Walled Carbon Nanotubes

Top Venues

Drug development and industrial pharmacy

Advanced pharmaceutical bulletin

Pharmaceutical development and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Maha F Emam, Nesrin F Taha, Nadia M Mursi, Laila Hassanian Emara
Preparation, characterization and in-Vitro/in-Vivo evaluation of meloxicam extruded pellets with enhanced bioavailability and stability. Drug development and industrial pharmacy 47 (1) (2020)
Nesrin F Taha, Maha F Emam, Laila Hassanian Emara
A novel combination of Soluplus®/Poloxamer for Meloxicam solid dispersions via hot melt extrusion for rapid onset of action. Part 2: comparative bioavailability and IVIVC. Drug development and industrial pharmacy 46 (8) (2020)
Asmaa Nabil Elboraey, Hanan Hassan Abo-Almaged, Ahmed Abd El-Rahman El-Ashmawy, Aya Rashad Abdou, Amani Ramadan Moussa, Laila Hassanian Emara, Hossam Mohammed El-Masry, Gehan El-Tabie El Bassyouni, Magda Ismail Ramzy
Biological and Mechanical Properties of Denture Base Material as a Vehicle for Novel Hydroxyapatite Nanoparticles Loaded with Drug. Advanced pharmaceutical bulletin 11 (1) (2020)
Ebtesam W Elsayed, Ahmed Abd El-Rahman El-Ashmawy, Nadia M Mursi, Laila Hassanian Emara
Optimization of gliclazide loaded alginate-gelatin beads employing central composite design. Drug development and industrial pharmacy 45 (12) (2019)
Laila Hassanian Emara, Ahmed Abd El-Rahman El-Ashmawy, Nesrin F Taha
Stability and bioavailability of diltiazem/polyethylene oxide matrix tablets. Pharmaceutical development and technology 23 (10) (2017)